ALFA Finder| Revenue growth | 11% YoY growth in FY26; 18% 3-year CAGR. |
|---|---|
| Margins | Services at 25% EBITDA; products at 10-12%. |
| Order book | Signed contracts for doubling service revenue; hiring 1,000+ employees for projects. |
| Demand visibility | Strong demand for patient support programs (PSPs) and GLP-1 therapy engagement. |
| Management confidence | High; visibility on service contracts and recurring patient engagement revenue. |
Growth
Revenue grew 11% to ₹172.9cr; EBITDA at ₹25.9cr (15% margin); PAT at ₹11.9cr. 3-year Revenue CAGR is 18%.
Outlook
Reiterated FY27 revenue guidance of ₹216cr; targeting doubling service segment revenue; EBITDA margin expected at 18-19%.
Risks
Supply chain disruptions and shipping delays impacted H2 product segment; margins hit by heavy pre-recruitment and tech costs.
Earnings Call filed with NSE, NSE: QMSMEDI. Summary written with AI assistance from the document.
QMS Medical Allied Services Ltd: key numbers
- Share price
- ₹170.59
- Market cap
- ₹329.9 Cr
- Revenue (annual)
- ₹172.9 Cr
- Net profit (annual)
- ₹11.92 Cr
- P/E (TTM)
- 27.7×Sector 54.5×
- Promoter holding
- 68.11%+0.00% QoQ
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from QMS Medical Allied Services Ltd
All →QMS Medical Allied Services Annual General Meeting
QMS Medical Allied Services Limited held its 9th Annual General Meeting on September 30, 2026. Shareholders approved a 5% final dividend and adoption of financial results.
QMS Medical Allied Services Acquisition
QMS Medical Allied Services Limited is acquiring BeamOptics Scientific Private Limited. The strategic acquisition aims to expand the company's addressable market in healthcare business.
- Execution
- on or before 30th November, 2027
QMS Medical Allied Services Business Update
QMS Medical Allied Services executed a shareholders' agreement with investors and its subsidiary, Saarathi Healthcare, defining governance rights, veto powers, and share transfer restrictions.
QMS Medical Allied Services Merger & Restructuring
QMS Medical Allied Services Limited approved a composite demerger scheme for its healthcare business and the acquisition of a 100% stake in BeamOptics Scientific Private Limited.
QMS Medical Allied Services Acquisition Worth ₹14.22 Cr
QMS Medical Allied Services Ltd acquired the remaining 24% stake in Saarathi Healthcare Private Limited for Rs. 14.23 Crore, making it a wholly-owned subsidiary.
- Value
- ₹14.22 Cr
QMS Medical Allied Services Other Announcement
QMS Medical Allied Services Limited informed the exchange regarding the dispatch of annual report links to shareholders who haven't registered their email addresses.